CLINDAMYCIN PHOSPHATE IN 5% DEXTROSE IN PLASTIC CONTAINER Drug Patent Profile

When do Clindamycin Phosphate In 5% Dextrose In Plastic Container patents expire, and what generic alternatives are available?

Clindamycin Phosphate In 5% Dextrose In Plastic Container is a drug marketed by Baxter Hlthcare Corp, Rising, and Sandoz Inc. and is included in three NDAs.

The generic ingredient in CLINDAMYCIN PHOSPHATE IN 5% DEXTROSE IN PLASTIC CONTAINER is clindamycin phosphate. There are fifty-five drug master file entries for this compound. Thirty-two suppliers are listed for this compound. Additional details are available on the clindamycin phosphate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Clindamycin Phosphate In 5% Dextrose In Plastic Container

A generic version of CLINDAMYCIN PHOSPHATE IN 5% DEXTROSE IN PLASTIC CONTAINER was approved as clindamycin phosphate by HIKMA on April 25^th, 1988.

Summary for CLINDAMYCIN PHOSPHATE IN 5% DEXTROSE IN PLASTIC CONTAINER

US Patents:	0
Applicants:	3
NDAs:	3
Finished Product Suppliers / Packagers:	4
Clinical Trials:	30
DailyMed Link:	CLINDAMYCIN PHOSPHATE IN 5% DEXTROSE IN PLASTIC CONTAINER at DailyMed

Recent Clinical Trials for CLINDAMYCIN PHOSPHATE IN 5% DEXTROSE IN PLASTIC CONTAINER

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Daré Bioscience, Inc.	Phase 1
Memorial Sloan Kettering Cancer Center	Phase 2
Daré Bioscience, Inc.	Phase 3

See all CLINDAMYCIN PHOSPHATE IN 5% DEXTROSE IN PLASTIC CONTAINER clinical trials

Pharmacology for CLINDAMYCIN PHOSPHATE IN 5% DEXTROSE IN PLASTIC CONTAINER

Drug Class	Lincosamide Antibacterial
Physiological Effect	Decreased Sebaceous Gland Activity Neuromuscular Blockade

US Patents and Regulatory Information for CLINDAMYCIN PHOSPHATE IN 5% DEXTROSE IN PLASTIC CONTAINER

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Sandoz Inc	CLINDAMYCIN PHOSPHATE IN 5% DEXTROSE IN PLASTIC CONTAINER	clindamycin phosphate	INJECTABLE;INJECTION	201692-001	May 31, 2012	AP	RX	No	Yes
Sandoz Inc	CLINDAMYCIN PHOSPHATE IN 5% DEXTROSE IN PLASTIC CONTAINER	clindamycin phosphate	INJECTABLE;INJECTION	201692-002	May 31, 2012	AP	RX	No	Yes
Rising	CLINDAMYCIN PHOSPHATE IN 5% DEXTROSE IN PLASTIC CONTAINER	clindamycin phosphate	INJECTABLE;INJECTION	203048-001	Apr 4, 2013	AP	RX	No	No
Baxter Hlthcare Corp	CLINDAMYCIN PHOSPHATE IN 5% DEXTROSE IN PLASTIC CONTAINER	clindamycin phosphate	INJECTABLE;INJECTION	208084-001	Jun 28, 2017	AP	RX	No	No
Baxter Hlthcare Corp	CLINDAMYCIN PHOSPHATE IN 5% DEXTROSE IN PLASTIC CONTAINER	clindamycin phosphate	INJECTABLE;INJECTION	208084-002	Jun 28, 2017	AP	RX	No	No
Baxter Hlthcare Corp	CLINDAMYCIN PHOSPHATE IN 5% DEXTROSE IN PLASTIC CONTAINER	clindamycin phosphate	INJECTABLE;INJECTION	208084-003	Jun 28, 2017	AP	RX	No	No

Clindamycin Phosphate in 5% Dextrose in Plastic Container: Market Dynamics and Financial Trajectory

Market Overview

Clindamycin phosphate, particularly in its formulation with 5% dextrose in plastic containers, is a crucial antibiotic used to treat severe bacterial infections. This market is driven by several key factors, including the increasing incidence of bacterial infections, the rise in antibiotic resistance, and advancements in healthcare infrastructure.

Market Size and Growth

The global clindamycin phosphate injection market, which includes the formulation in 5% dextrose, was valued at USD 451.67 million in 2023. It is projected to grow to USD 743.86 million by 2032, exhibiting a Compound Annual Growth Rate (CAGR) of 5.7% during the forecast period from 2024 to 2032[1][5].

Key Drivers of Growth

Rising Incidence of Bacterial Infections

The increasing prevalence of bacterial infections, especially in immunocompromised patients and those with skin and soft tissue infections, is a significant driver of the market. This trend is particularly pronounced in emerging markets where healthcare infrastructure is expanding[1].

Antibiotic Resistance

The growing issue of antibiotic resistance is driving the demand for effective antibiotics like clindamycin phosphate. This antibiotic remains potent against certain resistant bacterial strains, making it a preferred choice in critical care and surgical environments[1][5].

Expansion in Emerging Markets

The Asia Pacific and Latin America regions are experiencing rapid growth due to the expansion of healthcare infrastructure and the rising incidence of bacterial infections. Governments and healthcare organizations in these regions are prioritizing the availability of essential antibiotics, which includes clindamycin phosphate[1].

Development of Combination Therapies

Research into combination therapies involving clindamycin phosphate with other antibiotics is on the rise. This trend aims to enhance efficacy and combat complex infections, further driving market growth[1][5].

Market Segmentation

By Type

The market is segmented by type, including different vial sizes such as 2ml, 4ml, and 6ml. Each type has its specific applications and demand, influenced by the severity of infections and patient needs[5].

By End User

The end-user segmentation includes hospitals, clinics, and homecare settings. The trend towards outpatient and homecare settings is growing, supported by advancements in portable infusion technology[1].

By Region

North America currently holds the largest share of the global market, but the Asia Pacific region is experiencing the most rapid growth. This is due to the increasing prevalence of bacterial infections and the expanding healthcare infrastructure in countries like China, India, and Southeast Asian nations[1][5].

Financial Trajectory

Current Market Value

As of 2023, the global clindamycin phosphate injection market was valued at USD 451.67 million. It is expected to grow to USD 476.69 million in 2024 and reach USD 743.86 million by 2032[1][5].

Projected Growth

The market is projected to grow at a CAGR of 5.7% from 2024 to 2032. This steady growth is driven by the continuous need for potent antibiotics in critical care and surgical environments, as well as ongoing research into expanding the clinical applications of clindamycin phosphate[1][5].

Competitive Landscape

Companies in the clindamycin phosphate injection market are focusing on expanding their product portfolios and enhancing their distribution networks. Strategic partnerships and acquisitions are key components of their marketing strategy, enabling them to access new markets and strengthen their competitive position. Investing in research and development to innovate and improve product formulations is also crucial in addressing emerging antibiotic resistance issues[1].

Trends and Innovations

Shift Towards Homecare Settings

There is a growing trend towards administering antibiotics in outpatient and homecare settings, supported by advancements in portable infusion technology. This shift is expected to continue, driven by patient convenience and cost-effectiveness[1].

Focus on Antibiotic Stewardship

The increasing focus on antibiotic stewardship to combat resistance is a significant trend. This involves the responsible use of antibiotics to preserve their effectiveness and mitigate the risk of resistance[1][5].

Development of More Efficient Formulations

Research into more efficient topical and injectable formulations of clindamycin phosphate is ongoing. These innovations aim to enhance therapeutic efficacy and patient compliance, further driving market growth[2][4].

Regional Dynamics

Asia Pacific

The Asia Pacific region is experiencing rapid growth due to the increasing prevalence of bacterial infections and the expanding healthcare infrastructure in emerging economies such as China, India, and Southeast Asian countries. The rising population and improving access to healthcare services have led to a higher demand for effective antibiotics, including clindamycin phosphate[1].

Latin America

Latin America is also witnessing significant growth, driven by the rising incidence of bacterial infections and improving healthcare facilities. Governments and healthcare organizations in this region are prioritizing the availability of essential antibiotics, contributing to the market's expansion[1].

Key Takeaways

• The global clindamycin phosphate injection market is projected to grow from USD 476.69 million in 2024 to USD 743.86 million by 2032 at a CAGR of 5.7%.
• The market is driven by the increasing incidence of bacterial infections, antibiotic resistance, and expansion in emerging markets.
• The Asia Pacific region is experiencing the most rapid growth due to expanding healthcare infrastructure and rising demand for effective antibiotics.
• Companies are focusing on strategic partnerships, research and development, and targeted marketing efforts to capture market share.
• Trends include the shift towards homecare settings, focus on antibiotic stewardship, and development of more efficient formulations.

FAQs

What is the current market size of the clindamycin phosphate injection market?

The global clindamycin phosphate injection market was valued at USD 451.67 million in 2023.

What is the projected growth rate of the clindamycin phosphate injection market?

The market is projected to grow at a CAGR of 5.7% from 2024 to 2032.

Which region is experiencing the most rapid growth in the clindamycin phosphate injection market?

The Asia Pacific region is experiencing the most rapid growth due to the increasing prevalence of bacterial infections and the expanding healthcare infrastructure.

What are the key drivers of the clindamycin phosphate injection market?

Key drivers include the rising incidence of bacterial infections, antibiotic resistance, and the expansion of healthcare infrastructure in emerging markets.

What trends are shaping the clindamycin phosphate injection market?

Trends include the shift towards homecare settings, focus on antibiotic stewardship, and the development of more efficient formulations.

Sources

1. Polaris Market Research: Clindamycin Phosphate Injection Market Growth Report, 2032
2. The Business Research Company: Clindamycin Phosphate Topical Global Market Report 2024
3. Verified Market Research: Clindamycin Phosphate Topical Market Size, Share And Forecast
4. The Business Research Company: Clindamycin Phosphate Topical Global Market Report 2024
5. Polaris Market Research: Clindamycin Phosphate Injection Market Worth US$ 743.86 million ...